Due to their clinical advantages, synthetic mono-filament sutures are dominantly used for postoperative wound closures. We present two patients who suffered rare skin reactions to either poliglecaprone 25 or glyconate sutures, following breast cancer lumpectomy. This report aims to make perioperative practitioners and clinicians aware of reactions to sutures and possible management options.
Introduction
Reactions to suture material can prolong wound healing, compromise cosmetic results and increase the need for re-excision of the scar. Poliglecaprone 25 and glyconate are each synthetic mono-filamentous absorbable sutures used in adherence of soft tissue structures (Lu et al 2012) . The use of these sutures has increased recently in both general and plastic surgery due to their reported comparatively low tissue reactivity and pliability (LaBagnara 1995 , Molea et al 2000 . The first case we present describes a rare reaction to poliglecaprone 25 sutures, which provided us with the experience to manage and reassure the patient who suffered a similar reaction to glyconate sutures. To our knowledge, this is the first report of an adverse skin reaction to glyconate sutures in a surgical patient. It is important to recognize reactions to sutures in order to avoid their use in future procedures on the same patient. Additionally, recognition may prompt better patient allergy profiling preoperatively, as well as encouraging modifications to suture material by the manufacturer.
Case reports

Case 1
A 56-year-old woman, with no known allergies and no personal or known family history of hypertrophic or pathological scar formation, underwent an image-guided left wide local excision (WLE) and sentinel lymph node biopsy (SLNB) for breast cancer. The wound was repaired with 3/0 poliglecaprone 25 suture continuous subcuticular closure and n-butyl-2 cyanoacrylate glue. This was followed by a course of radiotherapy.
The immediate postoperative and post-radiotherapy periods were uneventful. However, six months after surgery, she presented with a tender and pruritic, hypertrophic lesion overlying the scar on the left breast ( Figure 1 ). Punch biopsy of the scar was performed to rule out local recurrence of the breast cancer due to the atypical clinical appearance. On histological examination, evidence of a fibrous reaction and foreign body material were seen without any additional significant abnormality.
As per the manufacturer specifications, sutures can take 91 to 119 days to be absorbed. Blood tests showed that the C reactive protein (CRP) level and white blood cell (WBC) count were within their respective normal ranges. The patient was followed up four months later, reassured and then discharged, with no further interventions required before discharge. Three years later, she was diagnosed with a malignant neoplasm of the contralateral breast and underwent a WLE and SLNB. To avoid a repeat skin reaction, polyglactin 910 sutures were used for layered closure (interrupted deep dermal and continuous subcuticular), along with n-butyl-2 cyanoacrylate glue. The alternative was using a non-absorbable continuous suture to be taken out in the immediate postoperative period. At 12 months postoperatively the patient reported no adverse reaction and the wound showed no evidence of hypertrophic or pathological scar formation (Figure 2 ). During both surgical procedures, skin sutures were placed by consultant surgeons.
Case 2
A 52-year-old woman with asthma and a known allergy to latex but no personal or known family history of hypertrophic or pathological scar formation, underwent a left WLE and SLNB. Two weeks later, she underwent reexcision for initial unclear tumour margins. Deep dermal and subcuticular closure was achieved with 3/0 glyconate sutures as well as n-butyl-2 cyanoacrylate glue in both operations, performed by the same consultant surgeon. According to the manufacturer these sutures can take 60 to 90 days to be absorbed. She then completed a radiotherapy regime.
Three months later, she presented with a nodular, hypertrophic scar ( Figure 3 ). Blood tests showed no elevation in WBC count or CRP level. With the experience of treating the patient in case 1, no investigations were performed. Treatment was initiated, with the option to punch biopsy the lesion at a later date if it did not settle.
The patient was prescribed hydrocortisone (1%), silicone gel and crotamiton cream and advised to apply them topically, twice a day. Two weeks later, an improvement was noted (Figure 4) . The patient was advised to continue with the hydrocortisone for four weeks and the silicone gel for eight weeks. She was subsequently discharged, with no further treatment required before discharge. 
Differential diagnosis
Diagnoses considered in both cases included a malignant recurrence and infection. The former was excluded in case 1 after reviewing the results of the punch biopsy. Infection was unlikely due to the nonacute, non-systemic presentation besides normal full blood count and CRP. This was also the reason for exclusion of infection as a possible diagnosis in case 2. Furthermore, on observation of the scar there were no clinical signs suggestive of inflammation and no discharge. A reaction to skin glue (n-butyl-2 cyanoacrylate) was suggested, however, this was dismissed due to the delayed nature and pattern of the reaction (Figures 1 and 3) , showing zig-zig nodularity across dual skin edges reflecting entry and exit points of the suture into dermis and subcuticular skin.
Discussion
Adverse reactions to suture material result in a hypertrophic scar that follows the suture line. Histologically, this is characterized by an abundance of fibroblasts and collagen resulting in granulomatous inflammation and fibrous changes. We performed a comprehensive search of the literature of Embase, Cochrane and Medline databases using variations of`poliglecaprone 25' and`glyconate' sutures along with synonyms for adverse outcomes. This returned 633 references, 20 of which were relevant after scrutinizing abstracts and full texts. This is the first report of an adverse reaction to glyconate sutures. Reactions to poliglecaprone 25 are rare in humans, however reactions in animal tissue have been identified histologically despite minimal changes being observed clinically (Runk et al 1999 , Ribeiro et al 2005 .
A comparison of the effect of nylon and poliglecaprone 25, used in internal and external sutures in rats, revealed an increased tissue reaction for poliglecaprone 25 for both types of suture. This was based on histologic analysis that revealed an increased number of inflammatory cells, including giant cells and fibroblasts associated with poliglecaprone 25 sutures (Ribeiro et al 2005) . Poliglecaprone 25 also elicited tissue reactions of the closure scar along the linea alba after ovariohysterectomies in cats (Runk et al 1999) . Histologic examination revealed evidence of granulomas and fibrosis, as well as eosinophilic inflammation noted in some cats as an early reaction, seven days postoperatively. However, these reactions in animals were short-lived and proposed to be consistent with expected postoperative wound healing.
In the two cases we report, sufficient time was left postoperatively to discriminate between expected surgical trauma and specific tissue reactivity. It may not be possible to immediately rule out infection or tumor recurrence since scar recurrences are not uncommon following malignancy, especially in invasive breast cancer, where local recurrence is estimated to be between 10-15% (Fowble 1999 , Freedman & Fowble 2000 . However, awareness of this form of sensitivity to suture material and the ability to identify this hypertrophic scar response may avoid unnecessary investigations on the patient.
The likelihood of tumor recurrence in our cases was low considering the relatively short timeframe in which these patients presented with scars. Ipsilateral breast tumor recurrence generally presents within years rather than months (Sakai et al 2015) . While both patients underwent radiotherapy, this did not exacerbate the scar, based on clinical examination of both patients and histological examination of the first case. Furthermore, the immediate post-radiotherapy period was uneventful. However, we are unable to comment on any histologic change in case 2, as there was no indication for biopsy but later resolution effectively ruled out any such possibility. In contrast, there is some evidence that radiation therapy may be beneficial in the treatment of hypertrophic scars (Berman et al 2016 , Gauglitz et al 2011 .
Conclusion
In summary, albeit rare, poliglecaprone 25 and glyconate can cause delayed skin reactions and may lead to over-investigation including invasive tests such as skin biopsy. Awareness of this possible complication by the surgical team can avoid unnecessary patient anxiety associated with biopsy in some cases. It is important to establish if a patient has a personal or family history of adverse reactions to synthetic material. This may be attained in the patient history during the preoperative assessment or by reviewing patient records. An alert system can then be implemented, notifying the surgical team of any risk factors for hypertrophic or pathologic scar formation. This may then influence the types of materials or equipment used during the surgical procedure. If a hypertrophic scar forms followed a surgical procedure, a trial of topical steroid cream is a potential treatment option when all other possible diagnoses have been excluded.
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